Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


T cells in SSc skin lesions: knowing your enemy

New research suggests that cytotoxic T cells are dominant in the lesional skin of patients with early diffuse cutaneous systemic sclerosis (SSc) and contribute to vasculopathy and tissue fibrosis. Could therapeutic strategies that prevent T cell activation and cytotoxicity therefore present an option to potentially halt progression of SSc?

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Model for the role of cytotoxic T cells in diffuse cutaneous systemic sclerosis.


  1. 1.

    Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet 390, 1685–1699 (2017).

    Google Scholar 

  2. 2.

    Maehara, T. et al. Cytotoxic CD4+ T lymphocytesmay induce endothelial cell apoptosis in systemic sclerosis. J. Clin. Invest. (2020).

    Article  PubMed  Google Scholar 

  3. 3.

    Chizzolini, C. & Boin, F. The role of the acquired immune response in systemic sclerosis. Semin. Immunopathol. 37, 519–528 (2015).

    CAS  Google Scholar 

  4. 4.

    Fuschiotti, P. et al. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum. 65, 236–246 (2013).

    CAS  PubMed Central  PubMed  Google Scholar 

  5. 5.

    Li, G. et al. Skin-resident effector memory CD8(+)CD28(-) T cells exhibit a profibrotic phenotype in patients with systemic sclerosis. J. Invest. Dermatol. 137, 1042–1050 (2017).

    CAS  Google Scholar 

  6. 6.

    Ayano, M. et al. Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis. J. Immunol. 195, 892–900 (2015).

    CAS  Google Scholar 

  7. 7.

    McMahan, Z. H. et al. Enrichment of scleroderma vascular disease-associated autoantigens in endothelial lineage cells. Arthritis Rheumatol. 68, 2540–2549 (2016).

    CAS  PubMed Central  PubMed  Google Scholar 

  8. 8.

    Boleto, G., Allanore, Y. & Avouac, J. Targeting costimulatory pathways in systemic sclerosis. Front. Immunol. 9, 2998 (2018).

    CAS  PubMed Central  PubMed  Google Scholar 

  9. 9.

    Bosurgi, L. et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science 356, 1072–1076 (2017).

    CAS  PubMed Central  PubMed  Google Scholar 

  10. 10.

    Lederer, D. J. & Martinez, F. J. Idiopathic pulmonary fibrosis. New Engl. J. Med. 378, 1811–1823 (2018).

    CAS  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Patrizia Fuschiotti.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fuschiotti, P. T cells in SSc skin lesions: knowing your enemy. Nat Rev Rheumatol 16, 253–254 (2020).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing